Reciprocal and complementary role of MET amplification and EGFR T790M mutation in acquired resistance to kinase inhibitors in lung cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/21062933

Clin. Cancer Res. 2010 Nov 15 16 22 5489-98

Download in:

View as

General Info

PMID
21062933